Amphastar Pharmaceuticals, Inc. — Director's Dealing 2015

Jun 18, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Amphastar Pharmaceuticals, Inc. (AMPH)
CIK: 0001297184
Period of Report: 2015-06-15

Reporting Person: Zhou Rong (EVP, Production)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-06-15	Common Stock	A	1544	$0.00	Acquired	27232	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-06-15	Employee Stock Option (right to buy)	$16.19	A	4685	Acquired	2025-06-15	Common Stock (4685)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	99668	Indirect
Common Stock	5000	Indirect

Footnotes

F1: The reported shares are represented by deferred stock units, or DSUs, which vest in four equal annual installments beginning on June 15, 2016.

F2: The shares are held of record by the Zhou Family Trust for which the reporting person serves as a trustee.

F3: The shares are held of record by the reporting person's spouse.

F4: Shares subject to the option vest in four equal annual installments beginning on June 15, 2016.